Mid-size Drugs Based on Peptides and Peptidomimetics : A New Drug Category / by Hirokazu Tamamura, Takuya Kobayakawa, Nami Ohashi.
2018
RS400-431
Linked e-resources
Linked Resource
Online Access
Concurrent users
Unlimited
Authorized users
Authorized users
Document Delivery Supplied
Can lend chapters, not whole ebooks
Details
Title
Mid-size Drugs Based on Peptides and Peptidomimetics : A New Drug Category / by Hirokazu Tamamura, Takuya Kobayakawa, Nami Ohashi.
Author
Tamamura, Hirokazu. author.
ISBN
9789811076916
981107691X
9789811076909
9811076901
981107691X
9789811076909
9811076901
Published
Singapore : Springer Singapore : Imprint: Springer, 2018.
Language
English
Description
1 online resource (xvii, 100 pages) : illustrations.
Item Number
10.1007/978-981-10-7691-6 doi
Call Number
RS400-431
Dewey Decimal Classification
615.1/9
Summary
This brief describes studies conducted by the authors on mid-size drugs utilizing peptides and peptidomimetics, and on the development of anti-HIV agents. Peptides are important biological molecules and have various physiological actions. Peptide-based drug discovery may help bring about the development of useful medicines that are highly safe and show potent pharmacological effects in small doses. Recently, it has been shown that there is an important drug-like space in the mid-sized region between low- and high-molecular-weight compounds. Thus, mid-size drugs such as peptide compounds are being focused on. To date, several peptidomimetics that mimic primary, secondary, and tertiary structures of peptides have been developed to maintain and improve biological activities and actions of peptides. In this book, the features and advantages of mid-size drugs are described in detail. In addition, the merits of utilizing peptidomimetics in the development of mid-size drugs are referred to. Understanding such peptide-derived mid-size drugs will lead to a comprehensive expansion of medicinal chemistry.#xE000;
Bibliography, etc. Note
Includes bibliographical references.
Access Note
Access limited to authorized users.
Digital File Characteristics
text file PDF
Added Author
Kobayakawa, Takuya. author.
Ohashi, Nami. author.
Ohashi, Nami. author.
Series
SpringerBriefs in pharmaceutical science & drug development.
Available in Other Form
Print version: 9789811076909
Linked Resources
Online Access
Record Appears in
Online Resources > Ebooks
All Resources
All Resources
Table of Contents
1. Introduction of Mid-Size Drugs and Peptidomimetics
2. Chloroalkene Dipeptide Isosteres as Peptidomimetics
3. Conformational-restricted Cyclic Peptides
4. Peptidomimetics that Mimic Secondary Structures of Peptides
5.Peptidomimetics that Mimic Tertiary Structures of Peptides
6. Conjugated Compounds Involving Peptides
7. Summary and Future Perspectives of Researches on Mid-Size Drugs.
2. Chloroalkene Dipeptide Isosteres as Peptidomimetics
3. Conformational-restricted Cyclic Peptides
4. Peptidomimetics that Mimic Secondary Structures of Peptides
5.Peptidomimetics that Mimic Tertiary Structures of Peptides
6. Conjugated Compounds Involving Peptides
7. Summary and Future Perspectives of Researches on Mid-Size Drugs.